News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current AGRX market cap is 2.55M. The company's latest EPS is USD -2.1098 and P/E is -0.28.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 749k | 4.1M | 10.88M | 19.59M |
| Operating Income | -18.86M | -49.05M | -71.01M | -41.43M | -19.88M |
| Net Income | -18.61M | -51.85M | -74.89M | -25.41M | -14.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 49.54M | 73.06M | 39.33M | 14.24M | 10.26M |
| Total Liabilities | 3.8M | 23.73M | 30.06M | 19.79M | 26.57M |
| Total Equity | 45.75M | 49.33M | 9.27M | -5.55M | -16.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.69M | -47.31M | -65.2M | -35.95M | -9.58M |
| Investing | -98k | -40.69M | 39.46M | -133k | N/A |
| Financing | 42.42M | 67.99M | 30.42M | 22.18M | 6.89M |
| Market Cap | 2.55M |
| Price to Earnings Ratio | -0.28 |
| Price to Sales Ratio | 0.21 |
| Price to Cash Ratio | 1.61 |
| Price to Book Ratio | -0.25 |
| Dividend Yield | - |
| Shares Outstanding | 6.86M |
| Average Volume (1 week) | 34.55k |
| Average Volume (1 Month) | 25.74k |
| 52 Week Change | 55.28% |
| 52 Week High | 0.486 |
| 52 Week Low | 0.20 |
| Spread (Intraday) | 0.03 (8.21%) |
| Company Name | Agile Therapeutics Inc (QB) |
| Address |
1111b s governors ave dover, delaware 19904 |
| Website | https://www.agiletherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
